- Home
- ELTX vs NAAS Comparison
ELTX vs NAAS Comparison
Compare ELTX & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- NAAS
- Stock Information
- Founded
- ELTX 2011
- NAAS 2019
- Country
- ELTX United States
- NAAS China
- Employees
- ELTX N/A
- NAAS N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- ELTX Health Care
- NAAS Consumer Discretionary
- Exchange
- ELTX Nasdaq
- NAAS Nasdaq
- Market Cap
- ELTX 49.7M
- NAAS 54.6M
- IPO Year
- ELTX 2021
- NAAS 2017
- Fundamental
- Price
- ELTX $4.16
- NAAS $3.05
- Analyst Decision
- ELTX Buy
- NAAS
- Analyst Count
- ELTX 2
- NAAS 0
- Target Price
- ELTX $10.00
- NAAS N/A
- AVG Volume (30 Days)
- ELTX 16.1K
- NAAS 179.6K
- Earning Date
- ELTX 11-07-2024
- NAAS 11-05-2024
- Dividend Yield
- ELTX N/A
- NAAS N/A
- EPS Growth
- ELTX N/A
- NAAS N/A
- EPS
- ELTX N/A
- NAAS N/A
- Revenue
- ELTX N/A
- NAAS $58,241,066.00
- Revenue This Year
- ELTX N/A
- NAAS $19.53
- Revenue Next Year
- ELTX N/A
- NAAS $151.36
- P/E Ratio
- ELTX N/A
- NAAS N/A
- Revenue Growth
- ELTX N/A
- NAAS 199.95
- 52 Week Low
- ELTX $2.96
- NAAS $1.42
- 52 Week High
- ELTX $11.45
- NAAS $61.60
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- NAAS 42.32
- Support Level
- ELTX $4.05
- NAAS $3.00
- Resistance Level
- ELTX $4.89
- NAAS $3.35
- Average True Range (ATR)
- ELTX 0.28
- NAAS 0.24
- MACD
- ELTX -0.06
- NAAS -0.03
- Stochastic Oscillator
- ELTX 27.37
- NAAS 20.00
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.